CASE STUDY 05 / 06
Ketoconazole–PABA cocrystal
Martin et al., Molecular Pharmaceutics 2020, 17, 919–932
10×
Challenge
Low aqueous solubility can limit the development potential of certain pharmaceutical compounds.
Scientific approach
The published research prepared and characterized a 1:1 ketoconazole–p-aminobenzoic acid cocrystal and investigated its physical and pharmacological properties.
Published findings
The study reported a tenfold increase in aqueous solubility and a 6.7-fold improvement in oral bioavailability in the reported experimental model; its safety findings require context and should not be generalized to clinical use.
Development relevance
Crystal engineering can modify material properties; development relevance must be assessed for each molecule and intended product.
Source
Martin et al., Molecular Pharmaceutics 2020, 17, 919–932; DOI 10.1021/acs.molpharmaceut.9b01178.